Clinical Trial

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Recruiting
View on ClinicalTrials.gov →
Summary
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Protocol Amendment History 8 changes
critical Recruitment opened 2026-05-12
critical Trial status changed: Withheld → Not Yet Recruiting 2026-04-30
critical Phase changed: not specified -> not applicable 2026-04-30
critical Primary endpoint(s) modified 2026-04-30
notable Enrollment changed: None -> 10 2026-04-30
notable Sponsor changed: [Redacted] -> Synchron, Inc. 2026-04-30
minor Trial arms changed: 0 -> 1 2026-04-30
notable Trial sites expanded: 0 -> 4 locations 2026-04-30
Trial Details
NCT Number NCT07543367
Lead Sponsor Synchron, Inc.
Conditions Neurological Disorder, ALS (Amyotrophic Lateral Sclerosis), Motor Neuron Disease, ALS - Amyotrophic Lateral Sclerosis, ALS
Enrollment 10 participants
Start Date 2026-04
Primary Completion 2027-06 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-11